Obstructive Lung Diseases Completed Phase 2 / 3 Trials for Tiotropium (DB01409)

Also known as: Obstructive Lung Disease / Lung Disease,Obstructive / Lung Disease, Obstructive / Lung Diseases, Obstructive

IndicationStatusPhase
DBCOND0068721 (Obstructive Lung Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0046356726 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)Treatment